← ANALYSTS · TIPRANKS
Danielle Brill · Truist Financial
Hits
56%
180 of 320 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+16.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
20
Buy / hold / sell: 18 / 2 / 0
Upside of the analyst’s targets
+149.2%
Average over 13 current targets, to the last price
The market’s answer to the ratings
+0.5%
Day-0 move against SPY in the rating’s direction, average over 8 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 2on TipRanks 07:35 | WVEIWMWave Life Sciences · $629M | Reiterated | Buy | — | — | −3.3%next day −1.5% · 5 days −9.6% | ↗ |
| Sep 24on TipRanks 07:15 | IMVTIWMImmunovant · $5.8B | Reiterated | Hold | — | — | −1.5%next day −2.6% · 5 days −0.6% | ↗ |
| Sep 23on TipRanks 07:55 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Buy | — | — | +1.0%next day +1.3% · 5 days +1.9% | ↗ |
| Sep 23on TipRanks 07:55 | RAPPIWMRapport Therapeutics, Inc. · $1.4B | Reiterated | Buy | — | — | −17.0%next day −0.8% · 5 days −0.9% | ↗ |
| Sep 22on TipRanks 10:35 | MAZEIWMMaze Therapeutics, Inc. · $1.5B | Reiterated | Buy | $64.00 | +132.5% | +26.8%next day −0.3% · 5 days −3.6% | ↗ |
| Sep 21on TipRanks 07:55 | IRONIWMDisc Medicine · $2.2B | Reiterated | Buy | — | — | −3.0%next day 0.0% · 5 days −4.2% | ↗ |
| Sep 18on TipRanks 07:45 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Buy | — | — | −2.6%next day +0.4% · 5 days +5.6% | ↗ |
| Sep 4on TipRanks 08:35 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | — | — | +6.8%next day +3.0% · 5 days −5.0% | ↗ |
| Aug 21on TipRanks 07:35 | SLDBIWMSolid Biosciences · $615M | Initiated | Buy | $16.00 → $20.00+25.0% | +261.7% | +1.8%next day −1.2% · 5 days +4.6% | ↗ |
| Aug 18on TipRanks 07:30 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,030 → $1,095+6.3% | +33.7% | +1.2%next day +3.8% · 5 days +2.9% | ↗ |
| Aug 12on TipRanks Aug 11 15:00 | UPBIWMUpstream Bio, Inc. · $185M | Reiterated | Buy | $43.00 → $25.00−41.9% | +805.8% | −4.4%next day −2.8% · 5 days −3.0% | ↗ |
| Aug 12on TipRanks Aug 11 08:45 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $102 → $107+4.9% | +61.2% | −0.8%next day −0.1% · 5 days −0.5% | ↗ |
| Aug 10on TipRanks 07:55 | TECXIWMTectonic Therapeutic · $410M | Reiterated | Buy | $60.00 | +190.6% | +5.6%next day −2.2% · 5 days +3.5% | ↗ |
| Aug 10on TipRanks 07:55 | INSMInsmed · $21.5B | Reiterated | Buy | $185 → $195+5.4% | +102.6% | +2.8%next day −1.3% · 5 days −4.7% | ↗ |
| Aug 7on TipRanks 08:01 | PRAXIWMPraxis Precision Medicines · $6.9B | Reiterated | Buy | $616 | +154.8% | −3.1%next day +1.7% · 5 days +1.3% | ↗ |
| Aug 6on TipRanks 07:35 | DNTHIWMDianthus Therapeutics · $4.2B | Reiterated | Buy | $110 → $128+16.4% | +77.6% | −2.1%next day −1.5% · 5 days −1.5% | ↗ |
| Aug 5on TipRanks 07:55 | HRMYIWMHarmony Biosciences Holdings · $2.2B | Reiterated | Hold | $29.00 → $34.00+17.2% | −10.4% | −1.2%next day +1.5% · 5 days +3.6% | ↗ |
| Aug 5on TipRanks 07:55 | PVLAIWMPalvella Therapeutics · $1.8B | Reiterated | Buy | $210 → $207−1.4% | +72.1% | +2.1%next day +0.2% · 5 days −0.2% | ↗ |
| Aug 3on TipRanks Jul 31 08:45 | NBIXNeurocrine · $13.9B | Reiterated | Buy | $213 | +57.0% | −10.8%next day −1.8% · 5 days −5.5% | ↗ |
| Jul 31on TipRanks 07:36 | WVEIWMWave Life Sciences · $629M | Reiterated | Buy | $15.00 | +379.2% | −5.1%next day +2.8% · 5 days +7.2% | ↗ |
| Jul 31on TipRanks Jul 30 09:45 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $235 | +1.0% | −2.3%next day −3.1% · 5 days −4.4% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗